Jennifer Buell

CIK 1711184 · See Remarks · last filed 2026-04-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$761.6K

Companies

3

Total Filings

35

Lifetime Open-Market Net

-$12.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
AGEN	See Remarks	19,738	$3.30	$65.1K	-$12.2K	23	2026-04-28
INKT	Chief Executive Officer	57,942	$12.02	$696.5K	$0	10	2026-01-14
Protagenic Therapeutics, Inc.\new (PTIXW) Delisted	Director	—	$0.01	—	$0	1	2024-03-29

Recent Filings · Page 3 of 4

35 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-09-29	INKT	Exer (M)	+695,750	$0	EDGAR
2023-01-11	INKT	Grant (A)	+171,990	$399.0K	EDGAR
2022-01-25	INKT	Grant (A)	—	$0	EDGAR
2021-07-02	AGEN	Grant (A)	+10,597	$58.2K	EDGAR
2021-04-05	AGEN	Grant (A)	+80,838	$232.0K	EDGAR
2020-12-21	AGEN	Grant (A)	—	$0	EDGAR
2020-07-21	—	Grant (A)	—	$0
2020-06-17	AGEN	Grant (A)	—	$0	EDGAR
2019-12-27	AGEN	Grant (A)	—	$0	EDGAR
2019-07-25	AGEN	Grant (A)	—	$0	EDGAR

Showing 21–30 of 35

Prev Page 3 of 4 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.